Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
News
Nature Biotechnology 25, 607–608 (1 June 2007) | doi:10.1038/nbt0607-607
FDA likely to further restrict erythropoietin use for cancer patients
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
